Hughes, Michael D.

Top Publications

Top Publications Authored or Co-Authored by "Hughes, Michael D."

• First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial

  The Lancet Infectious Diseases, Volume 11, No. 4, Year 2011, Citations 133
• Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

  Nature Microbiology, Volume 7, No. 11, Year 2022, Citations 57
• Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study

  The Lancet HIV, Volume 6, No. 9, Year 2019, Citations 54
• Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household

  PLoS ONE, Volume 18, No. 3 March, Article e0283290, Year 2023, Citations 44
• Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial

  Journal of the International AIDS Society, Volume 25, No. 6, Article e25905, Year 2022, Citations 33